PMID- 30657438
OWN - NLM
STAT- MEDLINE
DCOM- 20200730
LR  - 20200730
IS  - 1547-0164 (Electronic)
IS  - 0889-7077 (Print)
IS  - 0889-7077 (Linking)
VI  - 40
IP  - 3
DP  - 2019
TI  - The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) 
      initiation and engagement in treatment among patients with cannabis use disorders 
      in 7 US health systems.
PG  - 268-277
LID - 10.1080/08897077.2018.1544964 [doi]
AB  - Background: Cannabis use disorders (CUDs) have increased with more individuals 
      using cannabis, yet few receive treatment. Health systems have adopted the 
      Healthcare Effectiveness Data and Information Set (HEDIS) quality measures of 
      initiation and engagement in alcohol and other drug (AOD) dependence treatment, 
      but little is known about the performance of these among patients with CUDs. 
      Methods: This cohort study utilized electronic health records and claims data 
      from 7 health care systems to identify patients with documentation of a new index 
      CUD diagnosis (no AOD diagnosis </=60 days prior) from International Classification 
      of Diseases, Ninth revision, codes (October 1, 2014, to August 31, 2015). The 
      adjusted prevalence of each outcome (initiation, engagement, and a composite of 
      both) was estimated from generalized linear regression models, across index 
      identification settings (inpatient, emergency department, primary care, addiction 
      treatment, and mental health/psychiatry), AOD comorbidity (patients with CUD only 
      and CUD plus other AOD diagnoses), and patient characteristics. Results: Among 
      15,202 patients with an index CUD diagnosis, 30.0% (95% confidence interval [CI]: 
      29.2-30.7%) initiated, 6.9% (95% CI: 6.2-7.7%) engaged among initiated, and 2.1% 
      (95% CI: 1.9-2.3%) overall both initiated and engaged in treatment. The adjusted 
      prevalence of outcomes varied across index identification settings and was 
      highest among patients diagnosed in addiction treatment, with 25.0% (95% CI: 
      22.5-27.6%) initiated, 40.9% (95% CI: 34.8-47.0%) engaged, and 12.5% (95% CI: 
      10.0-15.1%) initiated and engaged. The adjusted prevalence of each outcome was 
      generally highest among patients with CUD plus other AOD diagnosis at index 
      diagnosis compared with those with CUD only, overall and across index 
      identification settings, and was lowest among uninsured and older patients. 
      Conclusion: Among patients with a new CUD diagnosis, the proportion meeting HEDIS 
      criteria for initiation and/or engagement in AOD treatment was low and 
      demonstrated variation across index diagnosis settings, AOD comorbidity, and 
      patient characteristics, pointing to opportunities for improvement.
FAU - Lapham, Gwen T
AU  - Lapham GT
AD  - Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
AD  - Department of Health Services, University of Washington School of Public Health, 
      Seattle, Washington, USA.
FAU - Campbell, Cynthia I
AU  - Campbell CI
AD  - Division of Research, Kaiser Permanente Northern California, Oakland, California, 
      USA.
FAU - Yarborough, Bobbi Jo H
AU  - Yarborough BJH
AD  - Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
FAU - Hechter, Rulin C
AU  - Hechter RC
AD  - Department of Research and Evaluation, Kaiser Permanente Southern California, 
      Pasadena, California, USA.
FAU - Ahmedani, Brian K
AU  - Ahmedani BK
AD  - Center for Health Policy and Health Services Research, Henry Ford Health System, 
      Detroit, Michigan, USA.
FAU - Haller, Irina V
AU  - Haller IV
AD  - Essentia Institute of Rural Health, Duluth, Minnesota, USA.
FAU - Kline-Simon, Andrea H
AU  - Kline-Simon AH
AD  - Division of Research, Kaiser Permanente Northern California, Oakland, California, 
      USA.
FAU - Satre, Derek D
AU  - Satre DD
AD  - Division of Research, Kaiser Permanente Northern California, Oakland, California, 
      USA.
AD  - Department of Psychiatry, Weill Institute for Neurosciences, University of 
      California San Francisco, San Francisco, California, USA.
FAU - Loree, Amy M
AU  - Loree AM
AUID- ORCID: 0000-0003-1634-7343
AD  - Center for Health Policy and Health Services Research, Henry Ford Health System, 
      Detroit, Michigan, USA.
FAU - Weisner, Constance
AU  - Weisner C
AD  - Division of Research, Kaiser Permanente Northern California, Oakland, California, 
      USA.
AD  - Department of Psychiatry, Weill Institute for Neurosciences, University of 
      California San Francisco, San Francisco, California, USA.
FAU - Binswanger, Ingrid A
AU  - Binswanger IA
AD  - Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.
AD  - Colorado Permanente Medical Group, Aurora, Colorado, USA.
AD  - Division of General Internal Medicine, University of Colorado School of Medicine, 
      Aurora, Colorado, USA.
LA  - eng
GR  - UG1 DA040314/DA/NIDA NIH HHS/United States
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, N.I.H., Extramural
DEP - 20190118
PL  - United States
TA  - Subst Abus
JT  - Substance abuse
JID - 8808537
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Cohort Studies
MH  - Comorbidity
MH  - Emergency Service, Hospital
MH  - Female
MH  - Health Services Research
MH  - Hospitalization
MH  - Humans
MH  - Linear Models
MH  - Male
MH  - Marijuana Abuse/diagnosis/epidemiology/*therapy
MH  - Mental Health Services/*statistics & numerical data
MH  - Middle Aged
MH  - Patient Participation/*statistics & numerical data
MH  - Prevalence
MH  - Primary Health Care
MH  - Psychiatry
MH  - Quality Assurance, Health Care
MH  - Substance-Related Disorders/epidemiology/therapy
MH  - United States/epidemiology
MH  - Young Adult
PMC - PMC6639163
MID - NIHMS1008584
OTO - NOTNLM
OT  - Cannabis
OT  - comorbidity
OT  - health services research
OT  - quality indicators
OT  - substance use disorder
OT  - treatment
EDAT- 2019/01/19 06:00
MHDA- 2020/07/31 06:00
PMCR- 2019/11/06
CRDT- 2019/01/19 06:00
PHST- 2019/01/19 06:00 [pubmed]
PHST- 2020/07/31 06:00 [medline]
PHST- 2019/01/19 06:00 [entrez]
PHST- 2019/11/06 00:00 [pmc-release]
AID - 10.1080/08897077.2018.1544964 [doi]
PST - ppublish
SO  - Subst Abus. 2019;40(3):268-277. doi: 10.1080/08897077.2018.1544964. Epub 2019 Jan 
      18.